Extracorporeal Membrane Oxygenation Rescue Therapy in a Case of Portopulmonary Hypertension During Liver Transplantation: A Case Report

被引:25
|
作者
Stratta, C. [1 ]
Lavezzo, B. [1 ]
Ballaris, M. A. [1 ]
Panio, A. [1 ]
Crucitti, M. [1 ]
Andruetto, P. [1 ]
Fanelli, V. [2 ]
Marra, W. Grosso [3 ]
Ranieri, M. V. [2 ]
Salizzoni, M. [1 ]
机构
[1] AO Citta Salute & Sci, Ctr Trapianto Fegato, Anestesia & Rianimaz 9, I-10126 Turin, Italy
[2] AO Citta Salute & Sci, Anestesia & Rianimaz 1, I-10126 Turin, Italy
[3] AO Citta Salute & Sci, Cardiol, I-10126 Turin, Italy
关键词
D O I
10.1016/j.transproceed.2013.07.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Portopulmonary hypertension has been reported in 2% to 9% of candidates for liver transplantation (OLT). If it is moderate to severe, it represents a contraindication to the procedure until pulmonary vasodilatative therapy has been optimized. We report the case of a 43-year-old man, scheduled for OLT due to alcoholic cirrhosis with hemosiderosis. His Model for End-Stage Liver Disease was 25 at that time. The preoperative evaluation showed a severe alteration of diffusion (pO(2) 68 mm Hg), without hepatopulmonary syndrome or portopulmonary hypertension (PPH) upon basal and dobutamine stress echocardiography. At the beginning of the OLT the hemodynamic profile showed mean pulmonary artery pressure (mPAP) 38 mm Hg, wedge pressure (WP) 19 mm Hg, cardiac output (CO) 9.1 L/min, pulmonary vascular resistance (PVR) 166 dyne s/cm(5), transpulmonary gradient ('TPG) 19 mm Hg, which lead us to promptly initiate inhaled nitric oxide (iNO) and intravenous epoprostenol 2 to 5 ng/kg/min. Upon graft reperfusion the hemodynamic profile was: mPAP 47 mm Hg, WP 23 mm Hg, CO 14.2 L/min, PVR 135 dyne s/cm(5), TPG 24 mm Hg, and at the end of surgery, mPAP 39 mm Hg, WP 20 mm Hg, CO 10.6 L/min, PVR 123 dyne s/cm(5), TPG 19 mm Hg. On postoperative day (POD) 3, we observed severe worsening of PPH: mPAP 60 mm Hg, WP 10 mm Hg, CO 9.8 L/min, PVR 395 dyne s/cm(5), TPG 50 mm Hg even with maximal pulmonary vasodilatatory therapy (ambrisentan 5 mg, intravenous sildenafil 20 mg x 3 and epoprostenol 22 ng/kg/min, iNO). Severe acute respiratory distress syndrome (ARDS) was presents. Therefore we decided to begin veno-venous extracorporeal membrane oxygenation (v-v ECMO) to correct the hypoxic vasoconstriction. Subsequent weaning from inotropic support with iNO and epoprostenol was possible on POD 7 due to mPAP 42 mm Hg, WP 15 mm Hg, CO 7.9 L/min, PVR 273 dyne s/cm(5), and TPG 27 mm Hg. On POD 11 he was weaned from ECMO due to: mPAP 40 mm Hg, WP 16 mm Hg, CO 6.5 L/min, PVR 295 dyne s/cm(5) and TPG 24 mm Hg. The patient was extubated on POD 17. The cardiac catheterization 1 month after OLT showed: mPAP 28 mm Hg, WP 13 mm Hg, CO 5.4 L/min, PVR 220 dyne s/cm(5) and TPG 15 mm Hg. ECMO rescue therapy in this "extreme" case allowed us to correct hypoxemia responsible for worsening of pulmonary hypertension allowing time to reach the goal of vasodilatatory therapy.
引用
收藏
页码:2774 / 2775
页数:2
相关论文
共 50 条
  • [21] Extracorporeal membrane oxygenation support following liver transplantation-A case series
    Goussous, Naeem
    Akbar, Hashem
    LaMattina, John C.
    Hanish, Steven I.
    Barth, Rolf N.
    Bruno, David A.
    CLINICAL TRANSPLANTATION, 2019, 33 (07)
  • [22] Endovascular repair with extracorporeal membrane oxygenation as a rescue strategy for aortobronchial fistula: a case report
    Kyosuke Takahashi
    Misa Kajitani
    Takaaki Kamada
    Wataru Takayama
    Yoshiro Kobayashi
    JA Clinical Reports, 3 (1)
  • [23] Extracorporeal membrane oxygenation rescue for severe pneumocystis pneumonia with the Macklin effect: a case report
    Huang, Guoqing
    Zhou, Liping
    Yang, Ning
    Wu, Ping
    Mo, Xiaoye
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [24] Cardiac tamponade during venoarterial extracorporeal membrane oxygenation: a case report
    E. J. M. Adriaansen
    J. A. J. Hermens
    M. Broome
    L. Pladet
    E. Dubois
    D. W. Donker
    C. L. Meuwese
    Journal of Medical Case Reports, 17
  • [25] Cardiac tamponade during venoarterial extracorporeal membrane oxygenation: a case report
    Adriaansen, E. J. M.
    Hermens, J. A. J.
    Broome, M.
    Pladet, L.
    Dubois, E.
    Donker, D. W.
    Meuwese, C. L.
    JOURNAL OF MEDICAL CASE REPORTS, 2023, 17 (01)
  • [26] Extracorporeal membrane oxygenation for early graft dysfunction in lung transplantation: A case report
    Ball, JW
    Noon, GP
    Short, HD
    Scheinin, SA
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1997, 16 (04): : 468 - 471
  • [27] Pharmacokinetics of ampicillin during venovenous extracorporeal membrane oxygenation: A case report
    Kim, Sarah
    Stucky, Nicholas L.
    Drummond, Wendi
    Elbarbry, Fawzy
    Footer, Brent W.
    PHARMACOTHERAPY, 2023, 43 (08): : 864 - 868
  • [28] Extracorporeal membrane oxygenation rescue after heart transplantation
    Ko, WJ
    Chen, YS
    Chou, NK
    Hsu, RB
    Wang, SS
    Chu, SH
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (07) : 2388 - 2391
  • [29] Coagulopathic-induced membrane dysfunction during extracorporeal membrane oxygenation: a case report
    Stammers, Alfred H.
    Fristoe, Lance W.
    Christensen, Kevin
    Deptula, Joseph
    Sydzyik, R. Troy
    Zavadil, Douglas
    Willett, Lynne
    PERFUSION-UK, 1997, 12 (02): : 143 - 149
  • [30] Extracorporeal Membrane Oxygenation for Neuroprotection. A Case Report
    Popugaev, K. A.
    Krugliakov, N. M.
    Belousova, K. A.
    Abudeev, S. A.
    Lobanova, I. N.
    Bagzhanov, G., I
    Semenov, M. S.
    Gubarev, K. K.
    Zakhlevny, A., I
    Zabelin, M., V
    Samoilov, A. S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 61 - 61